Evidence map›Paper›PMID 39063154›Full record

ArticleInternational journal of molecular sciences2024

Evaluation of a New Closed-System Automated RT-qPCR Assay for the Rapid Detection and Monitoring of Common Nucleophosmin Mutations in Patients with Acute Myeloid Leukemia.

Richard D Press, Dana Dressel, Michelle McBean, Ing S Tiong, Matthew W Anderson, David Pride, Aarthi Raman, Rachelle R Doom, Rajesh Kaldate

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in International journal of molecular sciences, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Richard D PressDepartment of Pathology, Knight Cancer Institute, Oregon Health and Science University, Portland, OR 97239, USA.ORCID 0000-0002-2103-5144
Dana DresselInternational Health Management Associates (IHMA), Schaumburg, IL 60173, USA.
Michelle McBeanPeter MacCallum Cancer Centre, Melbourne, VIC 3052, Australia.
Ing S TiongPeter MacCallum Cancer Centre, Melbourne, VIC 3052, Australia.ORCID 0000-0001-7417-4343
Matthew W AndersonCenetron Diagnostics, Austin, TX 78758, USA.
David PrideDepartment of Pathology, University of California, San Diego, CA 92103, USA.
Aarthi RamanCepheid, Sunnyvale, CA 94089, USA.
Rachelle R DoomCepheid, Sunnyvale, CA 94089, USA.
Rajesh KaldateCepheid, Sunnyvale, CA 94089, USA.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Quantitative assessment of nucleophosmin 1 (

Indexed as

Leukemia, Myeloid, AcuteMutationNuclear ProteinsNucleophosminReal-Time Polymerase Chain ReactionFemaleHumansMaleMiddle AgedNeoplasm, ResidualRetrospective StudiesNPM1 protein, humanNuclear ProteinsNucleophosminacute myeloid leukemiaminimal residual disease (MRD)monitoringnucleophosmin (NPM1) mutationpolymerase chain reaction

Identifiers

PMID39063154
PMCPMC11277538

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.